ASTX..$2.71.. Flush with cash & upcoming catalysts. Could be good for the share price in the short-term. Company has a market cap of 255m and has 130m cash in the bank with no debt. They are making money as well with royalties from Dacogen.
Astex Pharmaceuticals to Present at Oppenheimer Healthcare Conference